Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Opens New Israeli Ag-Bio Division

NEW YORK, Jan. 30 - Compugen has launched an agricultural biotech and plant genomics subsidiary charged with the humble task of accelerating and directing the process of evolution.


The new subsidiary, Agro-LEADS, continues Compugen's efforts to integrate computational biology and plant genomics with traditional agricultural techniques, Compugen said on Wednesday.


Based in Rehovot, Israel, Agro-LEADS will focus on developing seeds with improved traits. It also plans collaborations with outside researchers in crop protection, nutritionally improved crops, and the expression of therapeutic and industrial products in genetically engineered plants.


The subsidiary will be co-managed by Hagai Karchi and Rafael Meissner, who are also co-founders. Their team includes plant geneticists, bioinformaticists, molecular biologists, and traditional plant breeders.


Compugen is a publicly owned Israeli bioinformatics company.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.